Krahasoni metodat

	EORTC QLQ-C30	Pyetësori për Ndikimin e Fibromialgjisë	Pyetësori për Sëmundjen Parkinson-39
Fusha	Rezultatet shëndetësore	Rezultatet shëndetësore	Rezultatet shëndetësore
Familja	Process / pipeline	Process / pipeline	Process / pipeline
Viti i origjinës	1993	1991	1997
Krijuesi	Nico Aaronson et al.	Cynthia S. Burckhardt et al.	Crispin Jenkinson et al.
Lloji	Self-report quality of life questionnaire	Self-report symptom and functional impairment questionnaire	Self-report quality of life questionnaire
Burimi themelues	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.	Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357.
Emërtime të tjera	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire	PDQ-39, Parkinson's Disease Questionnaire, PDQ
Të lidhura	5	4	4
Përmbledhja	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.	The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders.